D. E. Shaw & Co., Inc. Finch Therapeutics Group, Inc. Transaction History

D. E. Shaw & Co., Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.91 - $5.11 $36,614 - $97,958	-19,170 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$5.02 - $10.47 $41,535 - $86,628	-8,274 Reduced 30.15%	19,170 $96,000
Q4 2021 Feb 14, 2022	BUY	$8.95 - $16.88 $245,623 - $463,254	27,444 New	27,444 $274,000

Ticker FNCH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,688,400
Market Cap $63.4M
Description
Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutics company, develops a novel class of orally administered biological drugs in the United States. The company's lead candidate is CP101, an orally administered microbiome capsule that is in Phase 3 clinical trial for the treatment of patients with recurrent Clostridioides diffi...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.